July 29 (Reuters) - Medical device maker Boston Scientific Corp BSX.N reported a second-quarter loss on Wednesday, hurt by lower demand for specialty medical devices as patients continued to defer elective procedures during the COVID-19 pandemic.
Net loss attributable to Boston Scientific was $153 million, or 11 cents per share, in the quarter ended June 30, compared with net earnings of $154 million, or 11 cents per share, last year.
Sales fell to $2.00 billion from $2.63 billion.
(Reporting by Trisha Roy and Mrinalika Roy in Bengaluru; Editing by Devika Syamnath)
((Trisha.Roy@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91 80 6182 3635;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.